MedElevator Войти в исследования
← Поиск публикаций

DOI 10.20945/2359-4292-2026-0080

Медицинская библиотека · Archives of endocrinology and metabolism · 2026

Prognostic factors and survival in parathyroid carcinoma: a 50-year single-center cohort study.

Silva Luiza Helena Crispim da, Pontes Letícia Almeida, Brescia Marília D'Elboux Guimarães, Martin Regina Matsunaga, Ledesma Felipe Lourenço, Sodré Hudson Sá, Alves Venâncio Avancini Ferreira, Montenegro Fábio Luiz de Menezes, Magnabosco Felipe Ferraz

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

This study aims to analyze the clinical characteristics and prognostic factors of patients with parathyroid carcinoma (PC) treated at a tertiary institution.

SUBJECTS AND

METHODS

This retrospective cohort included 30 patients with PC who were treated between 1970 and 2023 at a single reference center. Clinical, pathological, and survival data were reviewed and prognostic factors were evaluated.

RESULTS

Of the 30 cases, 16 (53.3%) were women. Mean age at diagnosis was 45.9 years, median follow-up was 60 months and mean tumor size was 33 mm. Median follow-up was 60 months. Disease recurrence occurred in 16 (53.3%) cases, with disease persistence in three (10.0%). Median disease-free survival was 80 months, with a 57% overall survival rate. Neither gender nor age showed significant impact on survival. Patients with lower-stage tumors (T1 by the AJCC/UICC and T1+T2 by the Shaha classification) had significantly better overall survival (p = 0.004 and p = 0.0018, respectively) and disease-free survival (p = 0.03 and p = 0.04, respectively) than those with more advanced stages (p = 0.03 and p = 0.04, respectively). Additionally, patients who experienced tumor recurrence after 36 months had significantly better survival outcomes than those with earlier recurrences (p = 0.02).

CONCLUSION

Advanced tumor stage (T3 by the Shaha or T2 and above by the AJCC/UICC) is associated with higher mortality in patients with PC. Furthermore, a disease-free interval exceeding 36 months emerged as a relevant factor associated with improved overall survival.

Для цитирования: Silva Luiza Helena Crispim da, Pontes Letícia Almeida, Brescia Marília D'Elboux Guimarães, Martin Regina Matsunaga, Ledesma Felipe Lourenço, Sodré Hudson Sá, Alves Venâncio Avancini Ferreira, Montenegro Fábio Luiz de Menezes, Magnabosco Felipe Ferraz. Prognostic factors and survival in parathyroid carcinoma: a 50-year single-center cohort study.. Archives of endocrinology and metabolism. 2026. DOI: 10.20945/2359-4292-2026-0080.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.